[1]
|
Cabanillas ME, McFadden DG, Durante C. Thyroid cancer[J]. Lancet, 2016, 388:2783-2795. doi: 10.1016/S0140-6736(16)30172-6 |
[2]
|
Liu C, Xiao C, Chen J, et al. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma:a study of 966 patients[J]. BMC Cancer, 2019, 19:622. doi: 10.1186/s12885-019-5835-6 |
[3]
|
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66:115-132. doi: 10.3322/caac.21338 |
[4]
|
Doubi A, Al-Qannass A, Al-Angari SS, et al. Trends in thyroid carcinoma among thyroidectomy patients:a 12-year multicenter study[J]. Ann Saudi Med, 2019, 39:345-349. doi: 10.5144/0256-4947.2019.345 |
[5]
|
Ambrosi F, Righi A, Ricci C, et al. Hobnail Variant of Papillary Thyroid Carcinoma:a Literature Review[J]. Endocr Pathol, 2017, 28:293-301. doi: 10.1007/s12022-017-9502-7 |
[6]
|
吴昕, 徐协群, 郑朝纪, 等.分化型甲状腺癌再次手术的临床分析[J].中国普外基础与临床杂志, 2017, 24:813-818. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgpwjcylczz201707008 |
[7]
|
李春华, 王朝晖, 陈锦, 等.分化型甲状腺癌再手术的并发症预防[J].中华内分泌外科杂志, 2017, 11:294-295. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=nfmwk201704008 |
[8]
|
Roh JL, Kim JM, Park CI. Central compartment reoperation for recurrent/persistent differentiated thyroid cancer:patterns of recurrence, morbidity, and prediction of postoperative hypocalcemia[J]. Ann Surg Oncol, 2011, 18:1312-1318. doi: 10.1245/s10434-010-1470-9 |
[9]
|
张波, 姜玉新, 李建初, 等.超声在甲状腺结节手术决策中的作用:北京协和医院11年回顾[J].协和医学杂志, 2015, 6:124-127. http://d.wanfangdata.com.cn/Periodical/xhyx201502011 |
[10]
|
徐景竹, 梁智勇, 王兴华, 等.甲状腺乳头状癌原发转移性与复发/持续转移性颈部淋巴结超声特征的比较[J].中国医学科学院学报, 2017, 39:675-681. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgyxkxyxb201705013 |
[11]
|
吴琼, 房世保, 李小毅, 等.甲状腺癌淋巴结清扫术前超声定位的作用[J].协和医学杂志, 2015, 6:338-342. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=xhyx201505005 |
[12]
|
莎仁高娃, 谭莉, 王振捷.甲状腺良性结节超声误诊声像图特征[J].协和医学杂志, 2016, 7:115-118. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=xhyx201602007 |
[13]
|
张浩.分化型甲状腺癌术后复发的处理策略[J].中华普外科手术学杂志(电子版), 2016, 10:373-375. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhptwksszz201605006 |
[14]
|
Wu X, Li BL, Zheng CJ, et al. Predictive factors for central lymph node metastases in papillary thyroid microcarcinoma[J]. World J Clin Cases, 2020, 8:1350-1360. doi: 10.12998/wjcc.v8.i8.1350 |
[15]
|
Tuttle RM, Morris LF, Haugen BR, et al. Thyroid-Differentiated and Anaplastic Carcinoma. In:AJCC Cancer Staging Manual[M]. 8th edition. New York:Springer, 2017:873-890. |
[16]
|
Adam MA, Thomas S, Hyslop T, et al. Exploring the relationship between patient age and cancer-specific survival in papillary thyroid cancer:rethinking current staging systems[J]. J Clin Oncol, 2016, 34:4415-4420. doi: 10.1200/JCO.2016.68.9372 |
[17]
|
Choi WR, Roh JL, Gong G, et al. Multifocality of papillary thyroid carcinoma as a risk factor for disease recurrence[J]. Oral Oncol, 2019, 94:106-110. doi: 10.1016/j.oraloncology.2019.05.023 |
[18]
|
Park YM, Wang SG, Lee JC, et al. Metastatic lymph node status in the central compartment of papillary thyroid carcinoma:a prognostic factor of locoregional recurrence[J]. Head Neck, 2016, 38 Suppl 1:E1172-E1176. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792245/ |
[19]
|
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer:The American Thyroid Association Guide-lines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer[J]. Thyroid, 2016, 26:1-133. doi: 10.1089/thy.2015.0020 |